Pfizer is one of the most talked-about businesses needing no introduction. The pharmaceutical king hit the lottery during the pandemic with the launch of its COVID-19 vaccine, which took revenues to a whole new level. Pfizer continues to thrive due to sales of its vaccines and COVID-19 pill, generating billions in revenue. Nevertheless, the road ahead might be a little bumpy as COVID-19 cases decline. However, the company's financial outlook, diversification plans, and cash positioning make it a highly attractive bet for the long haul. Pfizer Has Depth Beyond Its COVID-19 Vaccine Pfizer became a household name after the pandemic took everyone by storm.
https://www.tipranks.com/news/article/pfe-stock-has-plenty-in-the-tank-to-grow-despite-the-pandemic-fade?utm_source=advfn.com&utm_medium=referral